The face of MNC drug firms in India and champion of IPR protection, he oversaw the Swiss giant's India expansion, its forays into new therapies and setting up of its global service centre in......
The Organisation of Pharmaceutical Producers of India is planning to make non-prescription drugs made available through post offices in select districts of Karnataka, Andhra Pradesh and Uttar......
Five multinational pharmaceutical companies have preferred China over India for setting up research and development units due to the inadequacies in India's patent laws. Besides Novartis, the other......
Sandoz, the generic arm of Swiss drug maker Novartis, recently closed its facility developing active pharmaceutical ingredients (API) near Mumbai, a person close to the development told Business......
Daiichi Sankyo's acquisition of Ranbaxy Laboratories, India's biggest drug maker, may spur hostile takeovers and mergers in India's Rs 50,000 crore pharmaceutical industry, experts and industry......